Literature DB >> 32762908

Role of Cardiac Lymphatics in Myocardial Edema and Fibrosis: JACC Review Topic of the Week.

Ebba Brakenhielm1, Arantxa González2, Javier Díez3.   

Abstract

The cardiac lymphatic network plays a key role in regulation of myocardial extracellular volume and immune cell homeostasis. In different pathological conditions cardiac lymphatics undergo significant remodeling, with insufficient lymphatic function and/or lymphangiogenesis leading to fluid accumulation and development of edema. Additionally, by modulating the reuptake of tissue-infiltrating immune cells, lymphatics regulate immune responses. Available evidence suggests that both edema and inadequate immune response resolution may contribute to extracellular matrix remodeling and interstitial myocardial fibrosis. Interestingly, stimulation of lymphangiogenesis has been shown to improve cardiac function and reduce the progression of myocardial fibrosis during heart failure development after myocardial infarction. This review goes through the available clinical and experimental data supporting a role for cardiac lymphatics in cardiac disease, focusing on the current evidence linking poor cardiac lymphatic transport to the fibrogenic process and discussing potential avenues for novel biomarkers and therapeutic targets to limit cardiac fibrosis and dysfunction.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  VEGF-C; edema; fibrosis; inflammation; interstitial fluid pressure; lymphangiogenesis

Year:  2020        PMID: 32762908     DOI: 10.1016/j.jacc.2020.05.076

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

Review 1.  Lymphangiogenesis and Lymphatic Barrier Dysfunction in Renal Fibrosis.

Authors:  Jing Liu; Chen Yu
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 2.  Signaling cascades in the failing heart and emerging therapeutic strategies.

Authors:  Xin He; Tailai Du; Tianxin Long; Xinxue Liao; Yugang Dong; Zhan-Peng Huang
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

Review 3.  Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration.

Authors:  Diana Gonciar; Teodora Mocan; Lucia Agoston-Coldea
Journal:  Pharmaceutics       Date:  2022-03-26       Impact factor: 6.525

Review 4.  Multiple roles of cardiac macrophages in heart homeostasis and failure.

Authors:  Aneta Moskalik; Justyna Niderla-Bielińska; Anna Ratajska
Journal:  Heart Fail Rev       Date:  2021-08-13       Impact factor: 4.654

5.  Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension.

Authors:  LouJin Song; Xian Chen; Terri A Swanson; Brianna LaViolette; Jincheng Pang; Teresa Cunio; Michael W Nagle; Shoh Asano; Katherine Hales; Arun Shipstone; Hanna Sobon; Sabra D Al-Harthy; Youngwook Ahn; Steven Kreuser; Andrew Robertson; Casey Ritenour; Frank Voigt; Magalie Boucher; Furong Sun; William C Sessa; Rachel J Roth Flach
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

Review 6.  Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages.

Authors:  Sophie Besse; Sophie Nadaud; Elise Balse; Catherine Pavoine
Journal:  Cells       Date:  2022-04-06       Impact factor: 6.600

Review 7.  The role of lymphangiogenesis in cardiovascular diseases and heart transplantation.

Authors:  Rui-Cheng Ji
Journal:  Heart Fail Rev       Date:  2021-11-04       Impact factor: 4.654

Review 8.  Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches.

Authors:  Begoña López; Susana Ravassa; María U Moreno; Gorka San José; Javier Beaumont; Arantxa González; Javier Díez
Journal:  Nat Rev Cardiol       Date:  2021-02-10       Impact factor: 32.419

Review 9.  In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies.

Authors:  Sophie Bekisz; Louis Baudin; Florence Buntinx; Agnès Noël; Liesbet Geris
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

10.  Sirtuin 3 deficiency aggravates angiotensin II-induced hypertensive cardiac injury by the impairment of lymphangiogenesis.

Authors:  Chen Zhang; Na Li; Mengying Suo; Chunmei Zhang; Jing Liu; Lingxin Liu; Yan Qi; Xuehui Zheng; Lin Xie; Yang Hu; Peili Bu
Journal:  J Cell Mol Med       Date:  2021-06-27       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.